These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18797895)

  • 1. The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.
    Ohtsuka T
    Arch Dermatol Res; 2008 Nov; 300(10):545-50. PubMed ID: 18797895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.
    Ohtsuka T
    Int J Dermatol; 2010 May; 49(5):579-84. PubMed ID: 20534097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M; Gül M; Seyhan M
    Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin in childhood psoriasis.
    Perrett CM; Ilchyshyn A; Berth-Jones J
    J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
    Abe M; Ishibuchi H; Syuto T; Sogabe Y; Yokoyama Y; Ishikawa O
    J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile generalized circinate pustular psoriasis treated with oral cyclosporin A.
    Wollina U; Funfstuck V
    Eur J Dermatol; 2001; 11(2):117-9. PubMed ID: 11275806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
    Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
    J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
    Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
    Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
    J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
    Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis.
    Hirano T; Oka K; Umezawa Y; Hirata M; Oh-i T; Koga M
    Clin Pharmacol Ther; 1998 Apr; 63(4):465-70. PubMed ID: 9585801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.
    Ozawa A; Sugai J; Ohkido M; Ohtsuki M; Nakagawa H; Kitahara H; Tamaki K; Urabe K; Nakayama J; Horikoshi T; Morimoto Y; Jimbow K
    Eur J Dermatol; 1999; 9(3):218-23. PubMed ID: 10210789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A treatment in severe childhood psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.
    Hashimoto T; Kawakami T; Tsuruta D; Hamada T; Natsuaki Y; Fukuda S; Koga H; Sogame R; Ohyama B; Ono F; Karashima T; Nakama T; Dainichi T; Ishii N; Yasumoto S
    Australas J Dermatol; 2012 Aug; 53(3):202-6. PubMed ID: 22881466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis.
    Hayama K; Inadomi T; Fujisawa D; Terui T
    Eur J Dermatol; 2010; 20(6):758-62. PubMed ID: 21047721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.